Invasive cryptococcosis and adalimumab treatment

被引：19
作者：
Horcajada, Juan P. [1 ]
Pena, Jose L. [1 ]
Martinez-Taboada, Victor M. [1 ]
Pina, Trinitario [1 ]
Belaustegui, Isabel [1 ]
Cano, Maria Eliecer [1 ]
Garcia-Palomo, Daniel [1 ]
Farinas, M. Carmen [1 ]
机构：
[1] Univ Hosp Marques de Valdecilla, Infect Dis Unit, Santander 39008, Spain
来源：
EMERGING INFECTIOUS DISEASES | 2007年 / 13卷 / 06期
关键词：
D O I：
10.3201/eid1306.070154
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：953 / 955
页数：3
相关论文
共 10 条
  • [1] Descalzo MA, 2007, REUMATOL CLIN, V3, P4, DOI 10.1016/S1699-258X(07)73593-3
  • [2] Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies - Systematic review and meta-analysis of rare harmful effects in randomized controlled trials
    Bongartz, T
    Sutton, AJ
    Sweeting, MJ
    Buchan, I
    Matteson, EL
    Montori, V
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (19): : 2275 - 2285
  • [3] What makes Cryptococcus neoformans a pathogen?
    Buchanan, KL
    Murphy, JW
    [J]. EMERGING INFECTIOUS DISEASES, 1998, 4 (01) : 71 - 83
  • [4] Pulmonary cryptococcosis after initiation of anti-tumor necrosis factor-α therapy
    Hage, CA
    Wood, KL
    Winer-Muram, TH
    Wilson, SJ
    Sarosi, G
    Knox, KS
    [J]. CHEST, 2003, 124 (06) : 2395 - 2397
  • [5] Induction of interleukin-12 and gamma interferon requires tumor necrosis factor alpha for protective T1-cell-mediated immunity to pulmonary Cryptococcus neoformans infection
    Herring, AC
    Lee, J
    McDonald, RA
    Toews, GB
    Huffnagle, GB
    [J]. INFECTION AND IMMUNITY, 2002, 70 (06) : 2959 - 2964
  • [6] Huffnagle GB, 1996, J IMMUNOL, V157, P4529
  • [7] Safety analyses of adalimumab (HUMIRA) in global clinical trials and US postmarketing surveillance of patients with rheumatoid arthritis
    Schiff, M. H.
    Burmester, G. R.
    Kent, J. D.
    Pangan, A. L.
    Kupper, H.
    Fitzpatrick, S. B.
    Donovan, C.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (07) : 889 - 894
  • [8] Shrestha Rabin K, 2004, Respir Care, V49, P606
  • [9] True DG, 2002, J RHEUMATOL, V29, P1561
  • [10] US Food and Drug Administration, ARTHR DRUGS ADV COMM
1